Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 496

1.

Point Shear Wave Elastography by Acoustic Radiation Force Impulse Quantification in Comparison to Transient Elastography for the Noninvasive Assessment of Liver Fibrosis in Chronic Hepatitis C: A Prospective International Multicenter Study.

Friedrich-Rust M, Lupsor M, de Knegt R, Dries V, Buggisch P, Gebel M, Maier B, Herrmann E, Sagir A, Zachoval R, Shi Y, Schneider MD, Badea R, Rifai K, Poynard T, Zeuzem S, Sarrazin C.

Ultraschall Med. 2015 May 13. [Epub ahead of print]

PMID:
25970201
2.

Cognitive dysfunction and hepatitis C virus infection.

Solinas A, Piras MR, Deplano A.

World J Hepatol. 2015 May 8;7(7):922-5. doi: 10.4254/wjh.v7.i7.922.

3.

Real-time tissue elastography: non-invasive evaluation of liver fibrosis in chronic liver disease due to HCV.

Shiraishi A, Hiraoka A, Aibiki T, Okudaira T, Kawamura T, Imai Y, Tatsukawa H, Yamago H, Nakahara H, Shimizu Y, Suga Y, Azemoto N, Tanihira T, Miyata H, Miyamoto Y, Ninomiya T, Hirooka M, Abe M, Hiasa Y, Matsuura B, Kawasaki H, Furuya K, Michitaka K.

Hepatogastroenterology. 2014 Oct;61(135):2084-90.

PMID:
25713914
4.
5.

Noninvasive diagnosis of liver fibrosis: utility of data mining of both ultrasound elastography and serological findings to construct a decision tree.

Yada N, Kudo M, Kawada N, Sato S, Osaki Y, Ishikawa A, Miyoshi H, Sakamoto M, Kage M, Nakashima O, Tonomura A.

Oncology. 2014;87 Suppl 1:63-72. doi: 10.1159/000368147. Epub 2014 Nov 22.

PMID:
25427735
6.
7.

Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.

Enomoto M, Morikawa H, Tamori A, Kawada N.

World J Gastroenterol. 2014 Sep 14;20(34):12031-8. doi: 10.3748/wjg.v20.i34.12031. Review.

8.

Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients.

Koller T, Kollerova J, Huorka M, Meciarova I, Payer J.

Eur J Gastroenterol Hepatol. 2014 Oct;26(10):1108-15. doi: 10.1097/MEG.0000000000000182.

PMID:
25188444
9.

Chronic hepatitis C and liver fibrosis.

Sebastiani G, Gkouvatsos K, Pantopoulos K.

World J Gastroenterol. 2014 Aug 28;20(32):11033-53. doi: 10.3748/wjg.v20.i32.11033. Review.

10.

Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis.

Berenguer J, Zamora FX, Carrero A, Von Wichmann MA, Crespo M, López-Aldeguer J, Aldámiz-Echevarría T, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Esteban H, Bellón JM, González-García J; GESIDA HIVHCV Cohort Study Group.

J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):280-7. doi: 10.1097/QAI.0000000000000156.

PMID:
25157646
11.

Liver fibrosis evaluation by ARFI and APRI in chronic hepatitis C.

Li SM, Li GX, Fu DM, Wang Y, Dang LQ.

World J Gastroenterol. 2014 Jul 28;20(28):9528-33. doi: 10.3748/wjg.v20.i28.9528.

12.

Detailed evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests in assessing hepatic fibrosis.

Sertoglu E, Kayadibi H, Uyanik M.

J Clin Gastroenterol. 2015 Feb;49(2):170. doi: 10.1097/MCG.0000000000000187. No abstract available.

PMID:
25036410
13.

[Monitoring of patients with chronic hepatitis during and after therapy].

Colić-Cvrlje V, Ostojić R.

Acta Med Croatica. 2013 Oct;67(4):345-9. Croatian.

PMID:
24984335
14.

Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: a preliminary approach.

Alboraie M, Khairy M, Elsharkawy A, Elsharkawy M, Asem N, Abo El-Seoud AR, Elghamry FG, Esmat G.

Saudi J Gastroenterol. 2014 May-Jun;20(3):170-4. doi: 10.4103/1319-3767.133003.

15.

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C.

Boursier J, Brochard C, Bertrais S, Michalak S, Gallois Y, Fouchard-Hubert I, Oberti F, Rousselet MC, Calès P.

Aliment Pharmacol Ther. 2014 Jul;40(2):178-88. doi: 10.1111/apt.12813. Epub 2014 Jun 2.

PMID:
24889599
16.

Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C.

Silva Junior RG, Schmillevitch J, Nascimento Mde F, Miranda ML, Brant PE, Schulz PO, Vieira A, Szutan LA.

Scand J Gastroenterol. 2014 Aug;49(8):986-92. doi: 10.3109/00365521.2014.909528. Epub 2014 Apr 17.

PMID:
24742130
17.

Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis.

Ogawa E, Furusyo N, Nakamuta M, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Satoh T, Azuma K, Kawano A, Tanabe Y, Kotoh K, Shimoda S, Akahoshi T, Maehara Y, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group.

J Gastroenterol Hepatol. 2014 Sep;29(9):1728-35. doi: 10.1111/jgh.12619.

PMID:
24731162
18.

Current status of fibrosis markers.

Patel K, Shackel NA.

Curr Opin Gastroenterol. 2014 May;30(3):253-9. doi: 10.1097/MOG.0000000000000059. Review.

PMID:
24671009
19.

Non-invasive diagnosis of liver fibrosis in chronic hepatitis C.

Schiavon Lde L, Narciso-Schiavon JL, de Carvalho-Filho RJ.

World J Gastroenterol. 2014 Mar 21;20(11):2854-66. doi: 10.3748/wjg.v20.i11.2854. Review.

20.

Clinical, biochemical and pathological profiles of 5464 Egyptian chronic hepatitis C-infected patients.

Mabrouk M, El-Raziky M, Zayed N, Salama R, El-Akel W, Awad T, El Beshlawy M, Esmat G.

Hepatogastroenterology. 2013 Oct;60(127):1731-5.

PMID:
24634943
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk